Baird Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $539K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $666K | Buy |
|
|||||
|
2023
Q4 | $668K | Buy |
|
|||||
|
2023
Q3 | $647K | Buy |
|
|||||
|
2023
Q2 | $615K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.19M | Sell |
|
|||||
|
2022
Q3 | $3.04M | Buy |
|
|||||
|
2022
Q2 | $3.5M | Buy |
|
|||||
|
2022
Q1 | $3.37M | Buy |
|
|||||
|
2021
Q4 | $2.19M | Sell |
|
|||||
|
2021
Q3 | $30.6M | Buy |
|
|||||
|
2021
Q2 | $41.4M | Buy |
|
|||||
|
2021
Q1 | $38.2M | Sell |
|
|||||
|
2020
Q4 | $40.9M | Sell |
|
|||||
|
2020
Q3 | $35.8M | Sell |
|
|||||
|
2020
Q2 | $28.7M | Sell |
|
|||||
|
2020
Q1 | $26.9M | Sell |
|
|||||
|
2019
Q4 | $41.3M | Sell |
|
|||||
|
2019
Q3 | $38.5M | Sell |
|
|||||
|
2019
Q2 | $44.5M | Buy |
|
|||||
|
2019
Q1 | $43.4M | Buy |
|
|||||
|
2018
Q4 | $36.1M | Buy |
|
|||||
|
2018
Q3 | $47.6M | Sell |
|
|||||
|
2018
Q2 | $49.6M | Buy |
|
|||||
|
2018
Q1 | $35.3M | Buy |
|
|||||
|
2017
Q4 | $23.8M | Sell |
|
|||||
|
2017
Q3 | $27M | Sell |
|
|||||
|
2017
Q2 | $30.2M | Buy |
|
|||||
|
2017
Q1 | $3.62M | Buy |
|
|||||
|
2016
Q4 | $2.6M | Buy |
|
|||||
|
2016
Q3 | $2.71M | Buy |
|
|||||
|
2016
Q2 | $2.83M | Buy |
|
|||||
|
2016
Q1 | $2.46M | Buy |
|
|||||
|
2015
Q4 | $2.52M | Buy |
|
|||||
|
2015
Q3 | $2.34M | Buy |
|
|||||
|
2015
Q2 | $2.92M | Buy |
|